Eczema medication costing families thousands due to PBS age limit

A family in southern New South Wales advocates for the inclusion of Dupilumab on the Pharmaceutical Benefit Scheme for children under 12. Currently costing families up to $1,600 a month, the medication significantly improved the life of 10-year-old Tanner Hosie, who has severe eczema. A review by a PBAC advisory committee is expected in July to reassess its status.

Summary by Glance · ABC News – Australia